Published in TB and Outbreaks Week, March 7th, 2000
M.J. Wood and colleagues from the Birmingham Heartlands Hospital reported the need for alternate treatments because with the rise of Gram-positive bacterial pathogens, principally Staphylococcus aureus and enterococci, glycopeptide antibiotics were losing effectiveness.
Wood et al. stated, "there was, often, no therapeutic alternative to the glycopeptide antibiotics, vancomycin and teicoplanin, for empirical land often also the specific therapy of infections caused...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week